Population-Based Efficacy Modeling of Omalizumab in Patients with Severe Allergic Asthma Inadequately Controlled with Standard Therapy

Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 2

Abstract

The online version of this article (doi:10.1208/s12248-013-9463-9) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Rui Zhu, Yanan Zheng, Wendy S. Putnam, Jennifer Visich, Mark D. Eisner, John G. Matthews, Karin E. Rosen, David Z. D’Argenio

Keywords

Related Articles

In Vitro Characterization of a Novel Polymeric System for Preparation of Amorphous Solid Drug Dispersions

The online version of this article (doi:10.1208/s12248-014-9590-y) contains supplementary material, which is available to authorized users.

Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Rat Prefrontal Cortical Dopamine Response to Dual Acting Norepinephrine Reuptake Inhibitor and 5-HT1A Partial Agonist

The online version of this article (doi:10.1208/s12248-012-9343-8) contains supplementary material, which is available to authorized users.

Comparative evaluation of tableting compression behaviors by methods of internal and external lubricant addition: Inhibition of enzymatic activity of trypsin preparation by using external lubricant addition during the tableting compression process

This study evaluated tableting compression by using internal and external lubricant addition. The effect of lubricant addition on the enzymatic activity of trypsin, which was used as a model drug during the tableting com...

Common Deficiencies with Bioequivalence Submissions in Abbreviated New Drug Applications Assessed by FDA

A generic product must meet the standards established by the Food and Drug Administration (FDA) to be approved for marketing in the USA. FDA approves a generic product for marketing if it is proved to be therapeutically...

Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay

The online version of this article (doi:10.1208/s12248-015-9762-4) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681106
  • DOI  10.1208/s12248-013-9463-9
  • Views 47
  • Downloads 0

How To Cite

Rui Zhu, Yanan Zheng, Wendy S. Putnam, Jennifer Visich, Mark D. Eisner, John G. Matthews, Karin E. Rosen, David Z. D’Argenio (2013). Population-Based Efficacy Modeling of Omalizumab in Patients with Severe Allergic Asthma Inadequately Controlled with Standard Therapy. The AAPS Journal, 15(2), -. https://europub.co.uk/articles/-A-681106